Alpha Cognition Inc (ACOG) vs Fortress Biotech, Inc. (FBIOP)

A side-by-side comparison of Alpha Cognition Inc and Fortress Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Alpha Cognition Inc logo
ACOG
Alpha Cognition Inc
$139M
$8.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Fortress Biotech, Inc. logo
FBIOP
Fortress Biotech, Inc.
$146M
$18.58HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ACOG vs FBIOP

growth of $100 · dividends reinvested · last 2y
ACOG +28.9% (+13.5%/yr)FBIOP +232.7% (+82.4%/yr)FBIOP compounded faster over this window
100200300400Start $10020252026$129$333
ACOG FBIOP

ACOG vs FBIOP: by the numbers

  • •FBIOP is the larger company ($146M vs $139M market cap).
  • •FBIOP is profitable (163.32% net margin) while ACOG runs a net loss (-153.61%).

Metrics side by side

Valuation

MetricACOGFBIOP
P/E ratioN/A6.93
Forward P/EN/A7.29
P/S ratio9.142.14
P/B ratio2.630.89
FCF yieldN/A86.04%

Profitability

MetricACOGFBIOP
Gross margin81.26%62.53%
Operating margin-221.72%-111.00%
Net margin-153.61%163.32%
ROE-44.26%68.12%
ROIC-50.04%-10.85%

Growth (annualized)

MetricACOGFBIOP
Revenue CAGR (5Y)N/A5.39%
Total return CAGR (5Y)N/A0.05%

Frequently asked

Is ACOG or FBIOP more profitable?
FBIOP runs the higher net margin — ACOG at -153.61% versus FBIOP at 163.32%.

Go deeper

Full ACOG analysisFull FBIOP analysisInteractive comparison tool

Dig into the metrics

Fortress Biotech P/E ratioAlpha Cognition ROEFortress Biotech ROEAlpha Cognition operating marginFortress Biotech operating marginAlpha Cognition revenue growthFortress Biotech revenue growthAlpha Cognition free cash flowFortress Biotech free cash flow

Alpha Cognition & Fortress Biotech appear in these rankings

Highest ROE StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.